SHPH insider trading

NasdaqCM Healthcare

Shuttle Pharmaceuticals Holdings, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
27
Last 90 days
4
Buys / sells
22% / 63%
Market cap
$2.01M

About Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.

Company website: www.shuttlepharma.com

SHPH insider activity at a glance

FilingIQ tracks 27 insider transactions for SHPH in filings since Dec 30, 2022. The most recent transaction is dated Jul 14, 2026.

Across the full history, 6 open-market purchases and 17 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SHPH insider trades is 53.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest SHPH Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for SHPH?
FilingIQ tracks 27 Form 4 insider transactions for SHPH (Shuttle Pharmaceuticals Holdings, Inc.), covering filings from Dec 30, 2022 onwards. 4 of those are dated within the last 90 days.
Are SHPH insiders net buyers or net sellers?
Across the full Form 4 history for SHPH, 6 transactions (22%) were open-market purchases and 17 (63%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SHPH insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is SHPH in?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $2.01M.

Methodology & sources

Every SHPH insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.